Investors Appear Satisfied With JD Health International Inc.'s (HKG:6618) Prospects

Simply Wall St.11-04

When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") below 9x, you may consider JD Health International Inc. (HKG:6618) as a stock to avoid entirely with its 30.8x ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2480372736?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176","is_english":true,"pubTime":"2024-11-04 11:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2480372736","market":"us","top_or_hot":-1,"title":"Investors Appear Satisfied With JD Health International Inc.'s (HKG:6618) Prospects","media":"Simply Wall St.","content":"<div>\n<p>When close to half the companies in Hong Kong have price-to-earnings ratios (or \"P/E's\") below 9x, you may consider JD Health International Inc. (HKG:6618) as a stock to avoid entirely with its 30.8x ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/investors-appear-satisfied-with-jd-health-international-incs\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investors Appear Satisfied With JD Health International Inc.'s (HKG:6618) Prospects</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvestors Appear Satisfied With JD Health International Inc.'s (HKG:6618) Prospects\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-04 11:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/investors-appear-satisfied-with-jd-health-international-incs><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>When close to half the companies in Hong Kong have price-to-earnings ratios (or \"P/E's\") below 9x, you may consider JD Health International Inc. (HKG:6618) as a stock to avoid entirely with its 30.8x ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/investors-appear-satisfied-with-jd-health-international-incs\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4503","symbol_name":"景林资产持仓","start_time":0,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/investors-appear-satisfied-with-jd-health-international-incs","article_id":"2480372736","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2480372736","pubTimestamp":1730691396,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"When close to half the companies in Hong Kong have price-to-earnings ratios (or \"P/E's\") below 9x, you may consider JD...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"86618":"京东健康-R","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","IE00BGV7N243.SGD":"FSSA Global Emerging Markets Focus I Acc SGD","06618":"京东健康","LU0051755006.USD":"摩根大通中国A (dist)","LU1688375341.USD":"贝莱德中国灵活股票基金","BK4505":"高瓴资本持仓","BK4588":"碎股","BK4504":"桥水持仓","BK1591":"就地过年概念","BK1142":"互联网与直销零售","LU1880383366.USD":"东方汇理中国股票基金 A2 (C)","LU0106959298.USD":"UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) \"P\" (USD) ACC","BK4526":"热门中概股","BK1589":"北水核心资产","BK4531":"中概回港概念","BK4585":"ETF&股票定投概念","BK1515":"抗疫概念","BK1247":"药品零售","BK1583":"高瓴概念","BK4211":"区域性银行","ISBC":"投资者银行","BK4558":"双十一","BK4509":"腾讯概念","BK4220":"综合零售","SG9999002463.SGD":"LionGlobal China Growth SGD","BK4524":"宅经济概念","IE0008368742.USD":"首域中国增长基金I Acc","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","BK1571":"互联网医疗","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","BK4579":"人工智能","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD"},"translate_title":"投资者似乎对京东健康国际有限公司（HKG：6618）的前景感到满意","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"86618":0.6,"ISBC":1,"06618":1},"content_text":"When close to half the companies in Hong Kong have price-to-earnings ratios (or \"P/E's\") below 9x, you may consider JD Health International Inc. (HKG:6618) as a stock to avoid entirely with its 30.8x P/E ratio.  However, the P/E might be quite high for a reason and it requires further investigation to determine if it's justified.     JD Health International certainly has been doing a good job lately as it's been growing earnings more than most other companies.   The P/E is probably high because investors think this strong earnings performance will continue.  If not, then existing shareholders might be a little nervous about the viability of the share price.      View our latest analysis for JD Health International SEHK:6618 Price to Earnings Ratio vs Industry November 4th 2024 Keen to find out how analysts think JD Health International's future stacks up against the industry? In that case, our free report is a great place to start.  Does Growth Match The High P/E?   There's an inherent assumption that a company should far outperform the market for P/E ratios like JD Health International's to be considered reasonable.   Retrospectively, the last year delivered an exceptional 51% gain to the company's bottom line.   However, the latest three year period hasn't been as great in aggregate as it didn't manage to provide any growth at all.  Accordingly, shareholders probably wouldn't have been overly satisfied with the unstable medium-term growth rates.     Shifting to the future, estimates from the analysts covering the company suggest earnings should grow by 20% per year over the next three years.  With the market only predicted to deliver 12% per annum, the company is positioned for a stronger earnings result.  In light of this, it's understandable that JD Health International's P/E sits above the majority of other companies.  It seems most investors are expecting this strong future growth and are willing to pay more for the stock.    The Final Word  Generally, our preference is to limit the use of the price-to-earnings ratio to establishing what the market thinks about the overall health of a company.  As we suspected, our examination of JD Health International's analyst forecasts revealed that its superior earnings outlook is contributing to its high P/E.  At this stage investors feel the potential for a deterioration in earnings isn't great enough to justify a lower P/E ratio.  It's hard to see the share price falling strongly in the near future under these circumstances.      Many other vital risk factors can be found on the company's balance sheet.  Our free balance sheet analysis for JD Health International  with six simple checks will allow you to discover any risks that could be an issue.   If P/E ratios interest you, you may wish to see this free collection of other companies with strong earnings growth and low P/E ratios. New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2480372736"}